Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-028840
Filing Date
2016-09-12
Accepted
2016-09-12 21:52:33
Documents
1
Period of Report
2016-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10152
  Complete submission text file 0000899243-16-028840.txt   11502
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DR SE BOTHELL WA 98021
Business Address
SIEGALL CLAY B (Reporting) CIK: 0001167496 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 161881914